Salamanca woman jailed on murder, other charges
Breaking News
Salamanca woman jailed on murder, other charges
November 1, 2025
SALAMANCA — A city woman is facing murder and other felony charges after a death on River Street on Friday morning. The Salamanca Police Department re...
Home Online Features Lilly's Kisunla™ (donanemab-azbt) Receives Marketing Authorization in Great Britain for the Treatment of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in Adult Patients Who Are Apolipoprotein E Ε4 Heterozygotes or Non-Carriers
Lilly’s Kisunla™ (donanemab-azbt) Receives Marketing Authorization in Great Britain for the Treatment of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease in Adult Patients Who Are Apolipoprotein E Ε4 Heterozygotes or Non-Carriers
HO
Press Releases
Eli Lilly and Company  
October 23, 2024

Lilly’s Kisunla™ (donanemab-azbt) Receives Marketing Authorization in Great Britain for the Treatment of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease in Adult Patients Who Are Apolipoprotein E Ε4 Heterozygotes or Non-Carriers

Great Britain is the third major market where donanemab has received approval

logo salamanca press

Salamanca Press

email salamanca press
Local & Social